Mark K. Oki - Jan 17, 2022 Form 3 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Financial Officer
Signature
/s/ Josh Disbrow as attorney-in-facty for Mark K. Oki
Stock symbol
AYTU
Transactions as of
Jan 17, 2022
Transactions value $
$0
Form type
3
Date filed
1/19/2022, 10:40 AM
Next filing
Nov 28, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24.1 Power of Attorney